SCHEMBL14917853

SCHEMBL14917853

NC(=O)c1ccc(NC(=O)CCCc2noc(C(F)(F)F)n2)cc1

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.53
L3MBTL1 Q9Y468 2/20 0.52
KMT2A Q03164 4/20 0.52
MEN1 O00255 3/20 0.52
HDAC1 Q13547 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.48
PARP1 P09874 1/20 0.47
GLA P06280 1/20 0.45
TP53 P04637 2/20 0.44
LMNA P02545 1/20 0.44
POLB P06746 1/20 0.43
HDAC4 P56524 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14917930 0.97 MAPT (0.49) MAPTL3MBTL1KMT2AMEN1HDAC1
SCHEMBL14918142 0.96 L3MBTL1 (0.48) MAPTL3MBTL1KMT2AMEN1HDAC1
SCHEMBL14918280 0.96 L3MBTL1 (0.48) MAPTL3MBTL1KMT2AMEN1HDAC1
SCHEMBL14917904 0.96 L3MBTL1 (0.48) MAPTL3MBTL1KMT2AMEN1HDAC1
SCHEMBL14918498 0.93 HDAC6 (0.52) MAPTL3MBTL1KMT2AMEN1HDAC1
SCHEMBL14918878 0.88 HDAC6 (0.48) MAPTL3MBTL1KMT2AMEN1HDAC1
SCHEMBL14918059 0.88 KMT2A (0.58) MAPTL3MBTL1KMT2AMEN1HDAC1
SCHEMBL14918267 0.85 MEN1 (0.60) MAPTL3MBTL1KMT2AMEN1HDAC1
SCHEMBL14919134 0.85 HDAC1 (0.50) MAPTKMT2AMEN1HDAC1HDAC8
SCHEMBL14918418 0.84 RAB9A (0.46) MAPTL3MBTL1KMT2AMEN1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013066836-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2013-05-10 WO claimed
US-8871770-B2 Carboxamide compounds and methods for using the same MIDCAP FINANCIAL TRUST 2014-10-28 US disclosed
WO-2013066836-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2013-05-10 WO disclosed